Search results
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 11 hours ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 1 week agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga· 1 week agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 7 days agoThose products could range from RSV vaccines to individualized cancer treatments, which will help...
Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fall By Investing.com
Investing.com· 1 week agoModerna Inc. (NASDAQ:MRNA) reported first-quarter earnings and revenue that came ahead of analyst...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 1 week agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 7 days agoThis downturn aligns with the expected transition to a seasonal market for Covid-19 vaccines. During Q1 2023, Moderna received revenue from doses...
Tech Bytes: Moderna partners with OpenAI to expedite drug development processes
Proactive Investors· 3 days agoModerna, the biotechnology firm best known for its COVID-19 vaccines, has partnered with artificial...
Vaccine Maker Moderna Partners with OpenAI to Enhance Operations
iTech Post· 2 weeks agoNews of companies integrating AI functions in their operations is more expected now than surprising....
Moderna Focused on Cutting Costs, RSV Vaccine
Bloomberg· 1 week agoModerna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines. The drugmaker ...
